Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A12181 | 30573200 | Arch Med Res | Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models. | 2018 | Details |
A12197 | 30566676 | J Clin Endocrinol Metab | Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content. | 2019 | Details |
A12202 | 30563997 | J Clin Exp Hepatol | Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors. | 2018 | Details |
A12205 | 30562976 | J Clin Med | Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients. | 2018 | Details |
A12206 | 30562559 | Biochim Biophys Acta Mol Basis Dis | Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice. | 2018 | Details |
A12207 | 30561388 | J Clin Invest | STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. | 2018 | Details |
A12210 | 30561027 | Aliment Pharmacol Ther | Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease. | 2018 | Details |
A12217 | 30559024 | J Pediatr | Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. | 2018 | Details |
A12218 | 30558790 | Biochem Biophys Res Commun | Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease. | 2018 | Details |
A12220 | 30557902 | Diabetes Metab Res Rev | Apolipoprotein CIII and diabetes. Is there a link? | 2019 | Details |
A12221 | 30557833 | Biomed Pharmacother | Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol. | 2018 | Details |
A12223 | 30556145 | Hepatology | Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A12226 | 30556036 | Hepatol Commun | A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A12228 | 30555521 | Nutr Metab (Lond) | Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice. | 2018 | Details |
A12232 | 30554468 | Liver Int | Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals. | 2018 | Details |
A12238 | 30551613 | Nutrients | Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome. | 2018 | Details |
A12239 | 30551393 | Biomed Pharmacother | Enhanced hepatic glycogen synthesis and suppressed adenosine deaminase activity by lithium attenuates hepatic triglyceride accumulation in nicotine-exposed rats. | 2018 | Details |
A12248 | 30547890 | Eur Cytokine Netw | Obesity and inflammation. | 2018 | Details |
A12253 | 30545408 | J Med Case Rep | Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports. | 2018 | Details |
A12259 | 30543441 | Mol Pharm | Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice. | 2018 | Details |
A12260 | 30542827 | Obes Surg | Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients. | 2019 | Details |
A12266 | 30541128 | J Clin Endocrinol Metab | The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet. | 2019 | Details |
A12278 | 30537110 | Mol Nutr Food Res | Combination of Whole Grapeseed Flour and Newly Isolated Kefir Lactic Acid Bacteria Reduces High-Fat-Induced Hepatic Steatosis. | 2018 | Details |
A12279 | 30536914 | J Physiol | Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. | 2019 | Details |
A12285 | 30533179 | World J Hepatol | Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle? | 2018 | Details |
A12289 | 30528710 | Dig Liver Dis | Salivary markers of hepato-metabolic comorbidities in pediatric obesity. | 2018 | Details |
A12293 | 30526624 | J Transl Med | L-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice. | 2018 | Details |
A12296 | 30521580 | PLoS One | E4orf1: A protein for enhancing glucose uptake despite impaired proximal insulin signaling. | 2018 | Details |
A12297 | 30520566 | Obesity (Silver Spring) | Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study. | 2018 | Details |
A12300 | 30519965 | Acta Diabetol | A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? | 2018 | Details |
A12310 | 30504232 | J Lipid Res | Hepatic transcriptome analysis from HFD-fed mice defines a long noncoding RNA regulating cellular cholesterol levels. | 2018 | Details |
A12312 | 30503530 | Clin Biochem | A simpler diagnostic formula for screening nonalcoholic fatty liver disease. | 2018 | Details |
A12317 | 30516845 | Hepatology | Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis. | 2019 | Details |
A12330 | 30512987 | Am J Physiol Endocrinol Metab | Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver. | 2018 | Details |
A12335 | 30510243 | Exp Mol Med | Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression. | 2018 | Details |
A12339 | 30500887 | Endocr Rev | Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A12348 | 30496690 | Postgrad Med | Clinical workup of fatty liver for the primary care provider. | 2018 | Details |
A12363 | 30484310 | J Agric Food Chem | Folic Acid Reduced Triglycerides Deposition in Primary Chicken Hepatocytes. | 2018 | Details |
A12371 | 30483536 | JGH Open | Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial. | 2017 | Details |
A12373 | 30482910 | Nat Rev Gastroenterol Hepatol | The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2019 | Details |
A12378 | 30477827 | Complement Ther Med | The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial. | 2018 | Details |
A12379 | 30477455 | BMC Endocr Disord | Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial. | 2018 | Details |
A12383 | 30474798 | J Endocrinol Invest | Periostin concentrations in childhood-onset craniopharyngioma patients. | 2018 | Details |
A12384 | 30474288 | Obes Rev | Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity? | 2018 | Details |
A12390 | 30473057 | Metabolism | Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models. | 2018 | Details |
A12391 | 30473026 | Life Sci | p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease. | 2018 | Details |
A12397 | 30472683 | Gut | Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. | 2018 | Details |
A12401 | 30470912 | Diabetologia | Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. | 2018 | Details |
A12403 | 30469392 | J Clin Med | Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study. | 2018 | Details |
A12406 | 30468651 | Front Biosci (Landmark Ed) | Fructose at the crossroads of the metabolic syndrome and obesity epidemics. | 2019 | Details |
A12407 | 30467936 | Pediatr Diabetes | Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects. | 2018 | Details |
A12410 | 30466956 | Clin Nutr | Lean non-alcoholic fatty liver disease. | 2018 | Details |
A12414 | 30465824 | Free Radic Biol Med | Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia. | 2018 | Details |
A12421 | 30460863 | Pharm Biol | Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus. | 2018 | Details |
A12424 | 30459251 | Diabetes | Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis. | 2018 | Details |
A12426 | 30458848 | Lipids Health Dis | A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. | 2018 | Details |
A12431 | 30457913 | Am J Physiol Endocrinol Metab | Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity. | 2018 | Details |
A12433 | 30457067 | Proc Nutr Soc | Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state. | 2018 | Details |
A12434 | 30456918 | Diabetes Obes Metab | Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis? | 2018 | Details |
A12435 | 30455723 | Nutr Metab (Lond) | Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults. | 2018 | Details |
A12440 | 30454891 | Biochem Biophys Res Commun | Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress. | 2018 | Details |
A12442 | 30454829 | Clin Liver Dis | Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis? | 2019 | Details |
A12444 | 30454678 | Mutat Res Rev Mutat Res | Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease. | 2018 | Details |
A12446 | 30453990 | J Transl Med | Deficiency in interleukin-18 promotes differentiation of brown adipose tissue resulting in fat accumulation despite dyslipidemia. | 2018 | Details |
A12447 | 30453950 | BMC Complement Altern Med | Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR). | 2018 | Details |
A12449 | 30453660 | Nutrients | Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction. | 2018 | Details |
A12457 | 30447037 | Diabetes Obes Metab | Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes. | 2018 | Details |
A12458 | 30446932 | Hepatol Int | The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. | 2018 | Details |
A12459 | 30446669 | Nat Commun | Serotonin signals through a gut-liver axis to regulate hepatic steatosis. | 2018 | Details |
A12462 | 30445800 | Cancers (Basel) | Lipid Metabolic Reprogramming in Hepatocellular Carcinoma. | 2018 | Details |
A12463 | 30445758 | Children (Basel) | Extracellular Vesicles: A Potential Novel Regulator of Obesity and Its Associated Complications. | 2018 | Details |
A12471 | 30441981 | Vnitr Lek | Future of pharmacological treatment of non-alcoholic steatohepatitis in terms of key pathophysiological mechanisms. | 2019 | Details |
A12473 | 30431613 | Medicine (Baltimore) | The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population. | 2018 | Details |
A12474 | 30431378 | Curr Med Res Opin | Severe nonalcoholic steatohepatitis and type 2 diabetes: liver histology after weight loss therapy in a randomized clinical trial. | 2018 | Details |
A12486 | 30428868 | Lipids Health Dis | Changes in peroxisome proliferator-activated receptor alpha target gene expression in peripheral blood mononuclear cells associated with non-alcoholic fatty liver disease. | 2018 | Details |
A12487 | 30428692 | Diab Vasc Dis Res | Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2018 | Details |
A12492 | 30425763 | J Clin Med Res | Prevalence and Risk Factors of Elevated Liver Enzymes in Japanese Women With Polycystic Ovary Syndrome. | 2018 | Details |
A12494 | 30425219 | Indian J Med Res | Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents. | 2018 | Details |
A12496 | 30422676 | Am J Respir Crit Care Med | Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A12499 | 30420265 | Arab J Gastroenterol | Managing diabetes and liver disease association. | 2018 | Details |
A12502 | 30417996 | Pak J Biol Sci | Comparative Study of Orange and its Main Bioactive Constituents as Remedy for Non-alcoholic Fatty Liver in Rats. | 2018 | Details |
A12505 | 30415572 | Orv Hetil | [Non-alcoholic fatty liver disease - a summary and update based on the EASL-EASD-EASO Clinical Practice Guidelines of 2016]. | 2018 | Details |
A12506 | 30415544 | J Agric Food Chem | Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity. | 2018 | Details |
A12512 | 30414175 | J Sci Food Agric | Triticum aestivum ethanolic extract improves non-alcoholic fatty liver disease in mice fed a choline-deficient or high-fat diet. | 2019 | Details |
A12513 | 30413815 | Lab Invest | Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero. | 2018 | Details |
A12514 | 30413050 | Pharmaceuticals (Basel) | Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once? | 2018 | Details |
A12520 | 30411690 | Curr Comput Aided Drug Des | Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors. | 2019 | Details |
A12522 | 30411515 | Clin Obes | Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity. | 2018 | Details |
A12527 | 30409703 | Mol Metab | Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis. | 2018 | Details |
A12530 | 30408433 | Toxicol Appl Pharmacol | 6-gingerol ameliorates age-related hepatic steatosis: Association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction. | 2018 | Details |
A12533 | 30405551 | Front Microbiol | Endotoxemia by Porphyromonas gingivalis Injection Aggravates Non-alcoholic Fatty Liver Disease, Disrupts Glucose/Lipid Metabolism, and Alters Gut Microbiota in Mice. | 2018 | Details |
A12535 | 30404689 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Nonalcoholic Fatty Liver Disease and Weight Loss]. | 2018 | Details |
A12551 | 30394863 | Metab Syndr Relat Disord | Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers. | 2018 | Details |
A12554 | 30393477 | Arch Med Sci | Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis. | 2017 | Details |
A12556 | 30392752 | J Hepatol | Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women. | 2018 | Details |
A12560 | 30391126 | Trends Mol Med | Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism. | 2018 | Details |
A12561 | 30390352 | J Clin Lab Anal | Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease. | 2018 | Details |
A12565 | 30388763 | Nutrients | Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by "Junk Food": Evidence for Anti-Inflammatory Activity. | 2018 | Details |
A12566 | 30388740 | Nutrients | Fat Mass and Obesity Associated (FTO) Gene and Hepatic Glucose and Lipid Metabolism. | 2018 | Details |
A12567 | 30388378 | Can J Physiol Pharmacol | Histopathological and biochemical changes in the development of nonalcoholic fatty liver disease induced by high-sucrose diet at different times. | 2018 | Details |